Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children
Clinical trial NCT00764790 · COMPLETED
Trial details
- NCT number
- NCT00764790
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-03-05
- Enrollment
- 3317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.